Avid Bioservices ( (CDMO) ) just unveiled an announcement. Avid Bioservices, a biologics contract development and manufacturing organization, is set to be acquired by GHO Capital Partners and ...

November 8, 2024) - Rigrodsky Law, P.A. is investigating Avid Bioservices, Inc. ("Avid") (NASDAQ CM: CDMO) regarding possible breaches of fiduciary duties and other violations of law related to Avid's ...

One of the two candidates is expected to enter clinical development in 2025. In November, Nektar signed a definitive agreement with Ampersand Capital Partners to sell its commercial PEGylation Reagent ...

Nektar Therapeutics ( (NKTR) ) has released its Q3 earnings. Here is a breakdown of the information Nektar Therapeutics presented to its ...

PE Hub has spotted seven private equity deals involving franchises in the past six months. Here’s a look at the deals, ...

We feature 10 recent investments that show PE’s activity in the snack industry. They are in reverse chronological order. For ...

Mason Capital opposes Grifols sale to Brookfield Asset Management, raising concerns about the potential acquisition in the ...

AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...

The banking industry is expected to win big as former President Donald Trump returns to the White House, ushering in ...

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates The Merger Of Avid Bioservices, Inc. – CDMO ...

NEW YORK, Nov. 8, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches ...